Jacqualyn A. Fouse
Chief Financial Officer, Bunge Limited.
Companies
- MADRIGAL PHARMACEUTICALS, INC.Board member Mar 12, 2025 to now1
- Agios PharmaceuticalsBoard member Dec 5, 2017 to now2
- IncyteBoard member Nov 16, 2017 to now3
- Agios PharmaceuticalsChief executive officer Feb 5, 2019 to Apr 12, 20224
- Dick's Sporting GoodsBoard member Sep 16, 2010 to Mar 24, 20205
- Perrigo Company PlcBoard member Dec 20, 2013 to May 6, 20166
- Bunge LimitedChief financial officer Jul 24, 2007 to Sep 7, 20107
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Agios Pharmaceuticals AGIO154,156 shares8$5.3M at $34.36Jun 18, 2026
Incyte INCY20,968 shares9$2.4M at $113.77Jun 8, 2026- MADRIGAL PHARMACEUTICALS, INC. MDGL1,551 shares10$690.4K at $445.11Jun 17, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals8
- Jun 17, 2026Granted 454 shares of MADRIGAL PHARMACEUTICALS, INC.10
- Jun 8, 2026Granted 1,642 shares of Incyte9
- Jun 20, 2025Granted 203 shares of MADRIGAL PHARMACEUTICALS, INC.11
- Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals12
- Jun 10, 2025Granted 2,518 shares of Incyte13
- Apr 10, 2025Sold 7,497 shares at $25.90 of Agios Pharmaceuticals14
- Apr 8, 2025Exercised options 15,933 shares of Agios Pharmaceuticals14
- Mar 10, 2025Granted 894 shares of MADRIGAL PHARMACEUTICALS, INC.15
- Jun 13, 2024Exercised options 3,388 shares of Agios Pharmaceuticals16
- Jun 12, 2024Granted 2,830 shares of Incyte17
- Apr 10, 2024Sold 7,791 shares at $27.55 of Agios Pharmaceuticals18
- Apr 8, 2024Exercised options 15,934 shares of Agios Pharmaceuticals18
- Jan 24, 2024Sold 10,722 shares at $21.64 of Agios Pharmaceuticals19
- Jan 20, 2024Exercised options 23,900 shares of Agios Pharmaceuticals19
- Jan 9, 2024Sold 8,391 shares at $22.99 of Agios Pharmaceuticals20
- Jan 5, 2024Exercised options 17,500 shares of Agios Pharmaceuticals20
- Jun 30, 2023Sold 10,718 shares at $28.36 of Agios Pharmaceuticals21
- Jun 28, 2023Exercised options 23,900 shares of Agios Pharmaceuticals21
- Jun 14, 2023Granted 2,505 shares of Incyte22
- Apr 12, 2023Shares withheld for tax 4,731 shares at $21.35 of Agios Pharmaceuticals23
- Apr 8, 2023Exercised options 15,933 shares of Agios Pharmaceuticals23
- Feb 16, 2023Shares withheld for tax 3,648 shares at $28.91 of Agios Pharmaceuticals24
- Feb 14, 2023Exercised options 11,333 shares of Agios Pharmaceuticals24
- Dec 30, 2022Granted 252 shares at $80.32 of Incyte25
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAgios Pharmaceuticals, Board member
- 3SEC EDGARIncyte, Board member
- 4
- 5SEC EDGARDick's Sporting Goods, Board member
- 6SEC EDGARPerrigo Company Plc, Board member
- 7
- 8
- 9
- 10
- 11SEC EDGARForm 4 filed Jun 24, 2025
- 12SEC EDGARForm 4 filed Jun 23, 2025
- 13SEC EDGARForm 4 filed Jun 12, 2025
- 14SEC EDGARForm 4 filed Apr 10, 2025
- 15SEC EDGARForm 4 filed Mar 12, 2025
- 16SEC EDGARForm 4 filed Jun 17, 2024
- 17SEC EDGARForm 4 filed Jun 14, 2024
- 18SEC EDGARForm 4 filed Apr 10, 2024
- 19SEC EDGARForm 4 filed Jan 24, 2024
- 20SEC EDGARForm 4 filed Jan 9, 2024
- 21SEC EDGARForm 4 filed Jun 30, 2023
- 22SEC EDGARForm 4 filed Jun 16, 2023
- 23SEC EDGARForm 4 filed Apr 12, 2023
- 24SEC EDGARForm 4 filed Feb 16, 2023
- 25SEC EDGARForm 4 filed Jan 4, 2023